¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-18
±³À°ÀÏÀÚ : 2022-06-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ) ¹× ¼­¿ï·Ôµ¥È£ÅÚ 2Ãþ 3°³·ë  
±³À°ÁÖÁ¦ : (¿Â∙¿ÀÇÁ¶óÀÎ º´Çà) Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer2@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í 1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 10¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 10¸¸¿ø 2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 15¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 20¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-18 Room A 08:40~09:10 Modifiers of cancer immunity  Á¤ÁØÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-18 Room A 09:10~09:40 Novel discovery of antibody-drug conjugates for advanced cancers  Kaku Saito(Daiichi Sankyo, Inc, USA) 
±³À°½Ã°£ 06-18 Room A 09:40~10:10 PROTAC in cancer therapy  ½Éź¸(¿¬¼¼ÀÇ´ë) 
Åä·Ð 06-18 Room A 10:10~10:20 Q&A Discussion  () 
±³À°½Ã°£ 06-18 Room B 08:40~09:05 Addressing cancer care disparities through collaboration: opportunities and future directions  Winnie K.W.So(The Chinese University of Hong Kong, Hong Kong, China) 
±³À°½Ã°£ 06-18 Room B 09:05~09:30 Care of cancer survivors in a multi-disciplinary center  Janette Vardy(University of Sydney, Australia) 
±³À°½Ã°£ 06-18 Room B 09:30~09:55 Networking development and information sharing among Asian oncology nurses  ¼­Àº¿µ(¼­¿ï´ë °£È£´ë) 
±³À°½Ã°£ 06-18 Room B 09:55~10:20 Integration of supportive palliative care through the overall trajectory of cancer care  °í¼öÁø(¿ï»ê´ëÇб³º´¿ø) 
È޽Ġ06-18  10:20~10:40 È޽Ġ () 
±³À°½Ã°£ 06-18 Room A 10:40~11:05 Update of NTRK inhibitors for NTRK fusion-positive tumors  David S. Hong(The University of Texas MD Anderson Cancer Center , USA) 
±³À°½Ã°£ 06-18 Room A 11:05~11:30 Pembrolizumab for MSI-H or dMMR tumors  ¿Àµµ¿¬(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-18 Room A 11:30~11:55 HER2 targeted agents in breast, gut, and beyond  Á¤°æÇØ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-18 Room A 11:55~12:20 Novel clinical trial designs for tissue-agnostic drug development  ±èÁöÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-18 Room B 10:40~11:05 Endoscopic resection  Á¤ÈÆ¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-18 Room B 11:05~11:30 Surgical resection  Toshiro Nishida(National Cancer Center Hospital, Japan) 
±³À°½Ã°£ 06-18 Room B 11:30~11:55 Chemotherapy  Li-Tzong Chen(Kaohsiung Medical University, Taiwan) 
±³À°½Ã°£ 06-18 Room B 11:55~12:20 Molecular pathology of GISTs for precision medicine  ÀÌÇý½Â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-18 Room C 10:40~11:05 Algorithm based approach for spinal metastasis  Fon-Yih Tsuang(National Taiwan University Hospital, Taiwan) 
±³À°½Ã°£ 06-18 Room C 11:05~11:30 Total en block spondylectomy and immunotherapy for spinal metastasis  Kota Watanabe(Keio University School of Medicine, Japan) 
±³À°½Ã°£ 06-18 Room C 11:30~11:55 Recent update of radiotherapy for spinal bone metastasis  Arjun Sahgal(University of Toronto, Canada) 
±³À°½Ã°£ 06-18 Room C 11:55~12:20 Role of chemotherapy for spinal bone metastasis  ±èÅ¿ë(¼­¿ï´ëº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2022³â Á¦9Â÷ ½ºÆ÷Ã÷ÀÇÇÐ ÆÀÁÖÄ¡ÀÇ ½ÉÈ­±³À°°úÁ¤ : 2022-06-18
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ ¿Â¶óÀÎ ¿¬¼ö±³À° : 2022-06-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
330 ÃæºÏ ´ëÇѼҾưúÇÐȸ ÃæºÏ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-09-01 0 572 2018-08-08
329 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-09-01 0 643 2018-08-08
328 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¿¬¼¼º´¸® ½ÉÆ÷Áö¿ò : 2018-09-01 0 630 2018-08-08
327 ¼­¿ï ¼øõÇâ´ëÇб³ ¼­¿ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2018-08-31 0 881 2018-08-08
326 ¼­¿ï Á¦ 4ȸ ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¿¬¼ö±³À° : 2018-08-31 0 493 2018-08-08
325 ÀüºÏ Á¦20ȸ ¿µÈ£³²³»ºÐºñ´ë»çÇÐȸ Çмú´ëȸ : 2018-08-31 0 1,167 2018-08-08
324 ´ë±¸ ´ë±¸°æºÏ°³¿ø³»°úÀÇ»çȸ ¿¬¼ö°­Á : 2018-08-28 0 1,010 2018-08-08
323 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÒ¸éÁõ ÀÎÁöÇൿġ·á : 2018-08-26 0 1,631 2018-08-08
322 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø Á¦ 23ȸ °¡Å縯 ¾È°ú Çмú ½ÉÆ÷Áö¾ö : 2018-08-26 0 1,583 2018-08-08
321 ¼­¿ï ´ëÇÑ°³¿øÀÇÇùÀÇȸ 2018³âµµ Á¦2Â÷ ȸ¿ø¿¬¼ö±³À° : 2018-08-26 0 3,964 2018-08-08
320 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part3, 2ÀÏÂ÷) : 2018-08-26 0 833 2018-08-08
319 ¼­¿ï °í·Á´ëÇб³¾È»êº´¿ø Á¦14ȸ °í·ÁÀÇ´ë ÇǺΰúÇб³½Ç ½ÉÆ÷Áö¾ö ¹× ¿öÅ©¼ó : 2018-08-26 0 678 2018-08-08
318 ´ë±¸ 2018³â Á¦1ȸ ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ ¿¬¼ö°­Á : 2018-08-25 0 865 2018-08-08
317 ´ëÀü 2018 ´ëÇÑ¿Ü°ú¼ú±â¿¬±¸È¸ Ãß°è ½ÉÆ÷Áö¾ö ¹× Æ©ÅÍ ¿öÅ©¼ó : 2018-08-25 0 406 2018-08-08
316 Ãæ³² Àü³²´ëÇб³º´¿ø 2018 Á¦ 20Â÷ ºû°íÀ»½½°üÀý¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-08-25 0 694 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷